A novel structure-based virtual screening model for the hERG channel blockers
- PMID: 17331468
- DOI: 10.1016/j.bbrc.2007.02.068
A novel structure-based virtual screening model for the hERG channel blockers
Abstract
The hERG potassium channel is a key effector of cardiac repolarization and the blockade of this channel could cause arrhythmia. Thus, hERG channel blockade plays an important role for the potential pro-arrhythmic liability. In this report, binding of blockers to the hERG potassium channel is investigated using a combination of homology modeling, molecular docking, and molecular simulations, where blockade activities are evaluated using the linear regression model of GoldScore fitness. This structure-based virtual screening model is able to estimate the pIC(50) value of a wide range of ligands for the hERG potassium channel. The docked poses for ligands are also consistent with published mutation. Therefore, this model for the prediction of hERG channel blockade has the potential to provide cost-effective virtual screening tools for the evaluation of the cardiac liability of new chemical entities.
Similar articles
-
Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain.J Chem Inf Model. 2011 Feb 28;51(2):463-74. doi: 10.1021/ci100409y. Epub 2011 Jan 11. J Chem Inf Model. 2011. PMID: 21241063
-
Interaction simulation of hERG K+ channel with its specific BeKm-1 peptide: insights into the selectivity of molecular recognition.J Proteome Res. 2007 Feb;6(2):611-20. doi: 10.1021/pr060368g. J Proteome Res. 2007. PMID: 17269718
-
Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.J Med Chem. 2009 Jul 23;52(14):4266-76. doi: 10.1021/jm900002x. J Med Chem. 2009. PMID: 19534531
-
[HERG K+ channel, the target of anti-arrhythmias drugs].Yao Xue Xue Bao. 2007 Jul;42(7):687-91. Yao Xue Xue Bao. 2007. PMID: 17882949 Review. Chinese.
-
Tuning out of hERG.Curr Opin Drug Discov Devel. 2008 Jan;11(1):128-40. Curr Opin Drug Discov Devel. 2008. PMID: 18175275 Review.
Cited by
-
Astemizole Sensitizes Adrenocortical Carcinoma Cells to Doxorubicin by Inhibiting Patched Drug Efflux Activity.Biomedicines. 2020 Jul 29;8(8):251. doi: 10.3390/biomedicines8080251. Biomedicines. 2020. PMID: 32751066 Free PMC article.
-
Computational modeling of membrane proteins.Proteins. 2015 Jan;83(1):1-24. doi: 10.1002/prot.24703. Epub 2014 Nov 19. Proteins. 2015. PMID: 25355688 Free PMC article. Review.
-
Prediction of hERG Liability - Using SVM Classification, Bootstrapping and Jackknifing.Mol Inform. 2017 Apr;36(4):10.1002/minf.201600126. doi: 10.1002/minf.201600126. Epub 2016 Dec 21. Mol Inform. 2017. PMID: 28000393 Free PMC article.
-
Drug repositioning for personalized medicine.Genome Med. 2012 Mar 30;4(3):27. doi: 10.1186/gm326. eCollection 2012. Genome Med. 2012. PMID: 22494857 Free PMC article. Review.
-
Homology modeling and examination of the effect of the D92E mutation on the H5N1 nonstructural protein NS1 effector domain.J Mol Model. 2007 Dec;13(12):1237-44. doi: 10.1007/s00894-007-0245-0. Epub 2007 Oct 5. J Mol Model. 2007. PMID: 17917748
MeSH terms
Substances
LinkOut - more resources
Full Text Sources